SEATTLE, WA, Curi Bio, a leading developer of human stem cell-based platforms for drug discovery, has announced the second closing of a $10 million oversubscribed Series A financing. Read More
PLEASANTON, CA, Amador Bioscience, a global translational sciences and clinical pharmacology CRO, has raised a $60 million Series B+ financing. Read More
